Why Atlas Arteria's board rejected IFM Investors' takeover bid

IFM Investors' four-year campaign to take control of toll road operator Atlas Arteria culminated in a rejected bid worth up to $5.10 per share.

22 Jun 2026 · 6 min read

Toll road operator Atlas Arteria spent much of 2026 fending off a hostile takeover bid from major shareholder IFM Investors, a contest that Pendal Group's June 2026 Newsletter described as reaching its end point after IFM made its bid unconditional, flagged a higher final price, and set an expiry deadline, with its 38.5% ownership stake likely to fall short of the threshold needed to gain control given the board's continued opposition.

A four-year campaign for control comes to a head

Pendal Group's April 2026 Newsletter detailed how the bid evolved: IFM Investors, which first took a 20% stake in 2022 and had crept up its holding to 35% by early 2026, offered $4.75 per share cash, a 10% premium to the last close, rising to $5.10, an 18% premium, if acceptances took its holding above 45%. Resolution Capital's April 2026 Monthly Report noted the ALX board swiftly rejected the offer as opportunistic and materially undervaluing the business, a rejection Harvest Lane Asset Management's June 2026 Article said was supported by an independent review valuing the company at between $5.39 and $6.20 per share.

There is more value to be unlocked. The deal is structured in such a way that it's highly appealing to hedge funds like ourselves.

— Harvest Lane Asset Management, Article, June 2026

Beyond the takeover contest, the bid dynamics revealed longstanding frustrations with Atlas Arteria's largest asset. Pendal Group's May 2026 report suggested IFM's below-market opening bid, only 10% above the last close before rising to 18% conditional on a higher acceptance threshold, may reflect an attempt to top up its holding after a period of share price weakness and increase its board representation, having stated its opposition to management's strategy of pursuing new investments. Separately, the company had already been contending with a February 2026 setback when the French government deferred a planned reduction in the special tax on French motorways from 2026 to 2027, which Pendal described as the latest in a long-running pattern of French government interventions that destroy value for Atlas Arteria investors.

What managers are watching next

Following the board's rejection, Atlas Arteria began testing the market for a sale of its Chicago Skyway asset, a move Harvest Lane Asset Management said eliminates acquisition risk and could beat IFM's tiered takeover offer outright, even after its co-owner declined to exercise its right of first offer on the stake, a signal Pendal read as a negative indicator of achievable valuation. With IFM's bid deadline having passed without reaching a controlling stake, the Chicago Skyway sale process is now the clearer near-term catalyst for the stock.